Phase 1b Study of Pidnarulex and Trastuzumab Deruxtecan in Patients With HER2 Expressing Solid Tumors NCT07137416 · RECRUITING · Phase 1
Phase I Study Targeting DNA Methyltransferases in Metastatic Triple-Negative Breast Cancer NCT05673200 · RECRUITING · Phase 1
A Phase 1b Trial of ZEN003694 (ZEN-3694) With Pembrolizumab and Nab-Paclitaxel in Patients With Metastatic Triple-Negative Breast Cancer NCT05422794 · RECRUITING · Phase 1
A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response NCT04550494 · RECRUITING · Phase 2
A Phase 1 Study Evaluating Safety, Tolerability, and Preliminary Antitumor Activity of Entinostat and Nivolumab With or Without Ipilimumab in Advanced Solid Tumors NCT02453620 · ACTIVE NOT RECRUITING · Phase 1